572 related articles for article (PubMed ID: 27400746)
1. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Kazim SF; Iqbal K
Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
[TBL] [Abstract][Full Text] [Related]
2. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound.
Baazaoui N; Iqbal K
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291618
[TBL] [Abstract][Full Text] [Related]
4. Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound.
Baazaoui N; Iqbal K
Alzheimers Res Ther; 2017 Jun; 9(1):45. PubMed ID: 28655344
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
[TBL] [Abstract][Full Text] [Related]
6. Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice.
Wei W; Wang Y; Liu Y; Dai CL; Tung YC; Liu F; Iqbal K
Alzheimers Res Ther; 2020 Aug; 12(1):102. PubMed ID: 32854771
[TBL] [Abstract][Full Text] [Related]
7. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
Baazaoui N; Iqbal K
J Alzheimers Dis; 2017; 58(1):215-230. PubMed ID: 28387677
[TBL] [Abstract][Full Text] [Related]
9. GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update.
Chauhan N; Paliwal S; Jain S; Verma K; Paliwal S; Sharma S
Mini Rev Med Chem; 2022; 22(22):2881-2895. PubMed ID: 35450523
[TBL] [Abstract][Full Text] [Related]
10. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.
Hoppe JB; Coradini K; Frozza RL; Oliveira CM; Meneghetti AB; Bernardi A; Pires ES; Beck RC; Salbego CG
Neurobiol Learn Mem; 2013 Nov; 106():134-44. PubMed ID: 23954730
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the Molecular Role of Brain-Derived Neurotrophic Factor in Alzheimer's Disease.
Girotra P; Behl T; Sehgal A; Singh S; Bungau S
J Mol Neurosci; 2022 Feb; 72(2):173-186. PubMed ID: 34424488
[TBL] [Abstract][Full Text] [Related]
13. Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease.
Garcia P; Youssef I; Utvik JK; Florent-Béchard S; Barthélémy V; Malaplate-Armand C; Kriem B; Stenger C; Koziel V; Olivier JL; Escanye MC; Hanse M; Allouche A; Desbène C; Yen FT; Bjerkvig R; Oster T; Niclou SP; Pillot T
J Neurosci; 2010 Jun; 30(22):7516-27. PubMed ID: 20519526
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide Protects Against Brain Amyloid-β
Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
[TBL] [Abstract][Full Text] [Related]
15. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of neurodegeneration in Alzheimer's disease.
Crews L; Masliah E
Hum Mol Genet; 2010 Apr; 19(R1):R12-20. PubMed ID: 20413653
[TBL] [Abstract][Full Text] [Related]
17. Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease.
Jeong S
Mol Cells; 2017 Sep; 40(9):613-620. PubMed ID: 28927263
[TBL] [Abstract][Full Text] [Related]
18. Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.
Song JH; Yu JT; Tan L
Mol Neurobiol; 2015 Dec; 52(3):1477-1493. PubMed ID: 25354497
[TBL] [Abstract][Full Text] [Related]
19. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
20. Promoting Endogenous Neurogenesis as a Treatment for Alzheimer's Disease.
Zhang Q; Liu J; Chen L; Zhang M
Mol Neurobiol; 2023 Mar; 60(3):1353-1368. PubMed ID: 36445633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
